How High Novo Nordisk Could and Should Go for Ablynx Post author:Sam Post published:January 23, 2018 Post category:BioPharma Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace You Might Also Like Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives October 12, 2017 Cepheid Wins FDA Nod to Market Xpert Xpress Strep A October 4, 2017 3 Cases of Brain Damage Force the FDA to Slap a Hold on Bellicum's Lead Drug January 30, 2018